A Ristimaki

Summary

Affiliation: Helsinki University Central Hospital
Country: Finland

Publications

  1. pmc Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families
    Hannaleena Eerola
    Department of Oncology, Helsinki University Central Hospital, Haartmaninkatu, 00029 HUS, Helsinki Finland
    Breast Cancer Res 10:R17. 2008
  2. pmc Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder
    A Ristimaki
    Department of Pathology, Helsinki University Central Hospital, P O Box 140, FIN 00029 Helsinki, Finland
    Am J Pathol 158:849-53. 2001
  3. ncbi request reprint Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer
    Ari Ristimaki
    Department of Pathology, Molecular and Cancer Research Program, Helsinki University Central Hospital, P O Box 63 Haartmaninkatu 8, FIN 00014 Helsinki, Finland
    Cancer Res 62:632-5. 2002
  4. pmc Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer
    N Linder
    Developmental and Reproductive Biology and Hospital for Children and Adolescents, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
    J Clin Pathol 59:965-71. 2006
  5. ncbi request reprint Increased expression of cyclooxygenase-2 in malignant pheochromocytomas
    K Salmenkivi
    Department of Pathology, Haartman Institute, University of Helsinki and HUCH Laboratory Diagnostics, Helsinki University Central Hospital, FIN 00014 Helsinki, Finland
    J Clin Endocrinol Metab 86:5615-9. 2001
  6. pmc Prognostic role of CIP2A expression in serous ovarian cancer
    C BOCKELMAN
    Department of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland
    Br J Cancer 105:989-95. 2011
  7. ncbi request reprint Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression
    J Bizik
    Haartman Institute, University of Helsinki, POB 21, FIN 00014 Helsinki, Finland
    Cell Death Differ 11:183-95. 2004

Collaborators

  • K Salmenkivi
  • J Arola
  • J Lundin
  • Kristina Hotakainen
  • Anna Sivula
  • C BOCKELMAN
  • C Haglund
  • Hannaleena Eerola
  • N Linder
  • J Bizik
  • A Hemmes
  • R Butzow
  • J Westermarck
  • A Leminen
  • H Lassus
  • Outi Kilpivaara
  • Heli Nevanlinna
  • Kristiina Aittomaki
  • Carl Blomqvist
  • Paivi Heikkila
  • Anitta Tamminen
  • Mira Heinonen
  • M Lundin
  • A Kokkola
  • J Mrena
  • J P Wiksten
  • S Nordling
  • A Taieb
  • A Vaheri
  • W Lubitz
  • E Kankuri
  • H Vapaatalo

Detail Information

Publications7

  1. pmc Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families
    Hannaleena Eerola
    Department of Oncology, Helsinki University Central Hospital, Haartmaninkatu, 00029 HUS, Helsinki Finland
    Breast Cancer Res 10:R17. 2008
    ..Finding new immunohistochemical markers that are specific to hereditary breast cancer could help us to select candidates for BRCA1/BRCA2 mutation testing and to understand the biological pathways of tumour development...
  2. pmc Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder
    A Ristimaki
    Department of Pathology, Helsinki University Central Hospital, P O Box 140, FIN 00029 Helsinki, Finland
    Am J Pathol 158:849-53. 2001
    ....
  3. ncbi request reprint Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer
    Ari Ristimaki
    Department of Pathology, Molecular and Cancer Research Program, Helsinki University Central Hospital, P O Box 63 Haartmaninkatu 8, FIN 00014 Helsinki, Finland
    Cancer Res 62:632-5. 2002
    ..The present findings support efforts to initiate clinical trials on the efficacy of Cox-2 inhibitors in adjuvant treatment of breast cancer...
  4. pmc Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer
    N Linder
    Developmental and Reproductive Biology and Hospital for Children and Adolescents, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
    J Clin Pathol 59:965-71. 2006
    ..About half of the patients with breast cancer have a decrease in XOR expression. Patients with breast cancer with unfavourable prognosis are independently identified by the loss of XOR...
  5. ncbi request reprint Increased expression of cyclooxygenase-2 in malignant pheochromocytomas
    K Salmenkivi
    Department of Pathology, Haartman Institute, University of Helsinki and HUCH Laboratory Diagnostics, Helsinki University Central Hospital, FIN 00014 Helsinki, Finland
    J Clin Endocrinol Metab 86:5615-9. 2001
    ..These findings suggest that negative or weak Cox-2 expression in pheochromocytomas favors benign diagnosis...
  6. pmc Prognostic role of CIP2A expression in serous ovarian cancer
    C BOCKELMAN
    Department of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland
    Br J Cancer 105:989-95. 2011
    ..Our purpose was to study its role in serous ovarian cancer patients, and the association to clinicopathological variables and molecular markers...
  7. ncbi request reprint Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression
    J Bizik
    Haartman Institute, University of Helsinki, POB 21, FIN 00014 Helsinki, Finland
    Cell Death Differ 11:183-95. 2004
    ..Taken together, our results indicate that cell-cell contacts induce an actively programmed necrotic process that functionally involves COX-2, a known hallmark of inflammation and cancer...